gst tagged iqgap1 (Addgene inc)
Structured Review

Gst Tagged Iqgap1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 85/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gst+iqgap1/pmc10187324-127-0-4?v=Addgene+inc
Average 85 stars, based on 4 article reviews
Images
1) Product Images from "Coordination of actin plus-end dynamics by IQGAP1, formin, and capping protein"
Article Title: Coordination of actin plus-end dynamics by IQGAP1, formin, and capping protein
Journal: bioRxiv
doi: 10.1101/2023.05.04.539490
Figure Legend Snippet: (A) Schematic of IQGAP1 domains. Abbreviations: CHD, calponin homology domain; WW, WW domain; GRD, GAP-related domain; LBR, ligand binding region. (B) Images from TIRF assays containing 1 µM actin monomers (20% Oregon Green(OG)-label) and concentrations of IQGAP1. Scale bars, 25 µm. (C) Actin filament nucleation 200 s after initiation from reactions in B (n = 3 fields of view). Error bars indicate SE. Statistics, ANOVA: a, significantly different from control (No IQGAP1); ns, not different from control. (D) Actin filament elongation rates from TIRF reactions in B (n = 75 filaments per condition; pooled from 3 different trials). Statistics as in C. (E) Example actin filament that exhibits a pause in growth (red arrows). Scale bar, 3 µm. (F) Example length over time plots from reactions containing actin (grey) or actin and 75 nM IQGAP1 (teal). Red shading indicates the duration of filament pausing events. (G) Frequency distribution plots of the duration of IQGAP1 capping events from reactions measured in D (n = 75 filaments, and 31–70 pause events per condition, 331 pauses total measured). The mean duration of individual capping events was 20.6 s in the presence of IQGAP1 (regardless of concentration).
Techniques Used: Ligand Binding Assay, Control, Concentration Assay
Figure Legend Snippet: (A) IQGAP1 constructs that cap (+) and fail to cap (–) actin filaments. Specific functional regions and formin (mDia1) binding area are highlighted. DD, dimerization domain. Purple dots, two residues necessary for capping activity. (B) TIRF images from assays containing 1 µM actin (20% OG-label) or actin and 75 nM IQGAP1 proteins. CD, capping deficient. Scale bars, 25 µm. (C) Actin filament elongation rates from B (n = 75–324 filaments per condition; pooled from at least 3 different experiments). Error bars indicate SE. Statistics, ANOVA: a, significantly different from actin; b, significantly different from actin and 75 nM FL-IQGAP1. IQGAP1(CD) does not cap actin filaments shown by (D) filament length traces and (E) frequency plots of the duration of IQGAP1-mediated pauses (n = 75 filaments per condition; n = 159 pauses for IQGAP1; n = 12 for IQGAP1(CD)).
Techniques Used: Construct, Functional Assay, Binding Assay, Activity Assay
Figure Legend Snippet: (A) Single-molecules of labeled IQGAP1 or IQGAP1(CD) subjected to step-photobleaching. (B) Fluorescence intensity profiles of representative step photobleaching events for 5 nM SNAP-IQGAP1 proteins as imaged in A. Red lines emphasize photobleaching steps. (C) Fluorescence intensity predictions and analysis of SNAP-IQGAP1 molecules (n = 300 molecules per protein, pooled from 3 experiments) as in D-E. (D) Two-color TIRF images showing the localization of 649-IQGAP1 or 488-IQGAP1(CD). Reactions contain: 1 µM actin (10% 488- or 647-Alexa label) and 5 nM SNAP-IQGAP1 construct. Arrows depict filament end- or side-binding events. Scale bars, 5 µm. (E) Actin filament elongation rates comparing actin alone control with 5 nM untagged or 5 nM SNAP-tagged versions of IQGAP1. Conditions as in A (n = 33–75 filaments (dots) per condition pooled from 3 independent experiments). Error bars indicate SE. Statistics, ANOVA: a, significantly different from no IQGAP1 control; b, significantly different from actin and untagged IQGAP1; ns, not different from control. (F) Representative length traces of filaments from reactions in B. Red shading indicates the duration of filament capping events. (G) Percent of all actin filaments with labeled-IQGAP1 molecules present on the plus-end (n = 73–144 filaments per field of view, 335–372 measured total). (H) Percent of actin filaments from G with side bound IQGAP1 molecules. (I) Actin filament bundling was quantified at 1200 s from TIRF fields described in B, with skewness parameter (n = 3 fields of view per condition).
Techniques Used: Labeling, Fluorescence, Construct, Binding Assay, Control
Figure Legend Snippet: (A) Schematic of formin (mDia1) constructs that do not bind (FH1-C) or bind (∆DAD) to IQGAP1. Abbreviations: GBD, GTPase-binding domain; DID, Diaphanous inhibitory domain; FH1, formin homology region 1; FH2, formin homology 2 domain; DAD, Diaphanous autoregulatory domain. Structural features of mDia1 are labeled with green lines. DD, dimerization domain. (B) Single molecule colocalization of 10 nM 549-mDia1 constructs with 10 nM 649-IQGAP1 or 10 nM 488-IQGAP1(CD) by TIRF. Arrows highlight examples of SNAP-IQGAP1 (pink), SNAP-mDia1 (green) or colocalized molecules (white). Scale bars, 5 µm. (C) Colocalization of formin-IQGAP1 complexes as in B. Error bars indicate SE. Dots are individual values for n = 3–4 replicates. Statistics, ANOVA: a, significantly more association compared to mDia1(FH1-C). (D) Triple-color TIRF of actin filaments (blue; 10% 488- or 647-Alexa label) polymerizing in the presence of 5 µM profilin, 10 nM 549-mDia1(∆DAD) (green), and 10 nM 649-IQGAP1 or 488-IQGAP1(CD) (pink). Arrows as in B. Scale bars, 3 µm. (E) Elongation rates correlate with arrival and dissociation of 649-IQGAP1 or mDia1(∆DAD) at the barbed end. (F) Effects of IQGAP1 on the rate of mDia1-mediated actin filament elongation. Reactions as in D with unlabeled proteins. (G) Effects of IQGAP1(CD) on the rate of mDia1-mediated elongation. Reactions as described in D. Error bars in F-G indicate SE. Dots in F-G represent individual filaments measured (n = 24–105 per condition, pooled from at least 3 independent trials). Statistics as in C: a, different from actin alone and formin controls lacking profilin; b, different from reactions containing formin and profilin.
Techniques Used: Construct, Binding Assay, Labeling
Figure Legend Snippet: (A) Schematic of approach. Pink filament seeds with available ends will become bicolor filaments upon addition of blue actin monomers (free ends) or remain pink (blocked/capped ends). (B) Two-color actin filament assay visualized by TIRF. Reactions contain biotinylated 647-actin filament “seeds” polymerized for 2–3 mins before the reaction volume is replaced with 0.5 µM free-actin monomers (20% OG (top row only) or 10% 488-Alexa label) and buffer (control), 250 nM IQGAP1, 250 nM IQGAP1(CD), or 10 nM CP. (C) Quantification of blocked ends from reactions in B. Statistics, ANOVA: a, significantly different from control; b, significantly different from reactions containing IQGAP1. (D) Reactions performed as in B with the following conditions: buffer or 10 nM mDia1 protein, or 250 nM IQGAP1. (E) Quantification and statistics as in C for reactions in D. (F) Reactions performed as in B and D in the following combinations: buffer, CP, CP and mDia1(∆DAD), CP and IQGAP1, or CP, mDia1(∆DAD), and IQGAP1. All scale bars, 10 µm. (G) Quantification and statistics as in C for reactions in F.
Techniques Used: Control
Figure Legend Snippet: (A) Four-color TIRF microscopy images of plus-end complexes. Reactions contain: 1 µM actin (30% 405-Alexa label), 10 nM 488-mDia1(∆DAD), 10 nM 549-CP, and 10 nM 649-IQGAP1. Scale bars, 2 µm. (B) Fluorescence intensity for examples in (A) showing the formation or dissolution of plus-end complexes. (C) Dissociation of single molecules and complexes from actin filament plus-ends. (D) The plus-end half-life of each complex determined in C.
Techniques Used: Microscopy, Fluorescence, Dissolution
Figure Legend Snippet: (A) Representative cell morphology of 3T3 cells expressing endogenous IQGAP1 (green), IQGAP1 (−/−) (blue), IQGAP1 (−/−) transfected with Halo-IQGAP1 (pink), or IQGAP1 (−/−) transfected with Halo-IQGAP1(CD), plated on micropatterns. Scale bars, 10 µm. (B) Quantification of mean fluorescence (pixel count) from cells in A. Dots represent values from individual cells (n = 20–41 cells). Error bars, SE. Statistics, ANOVA: a, significantly different from endogenous; b, significantly different from IQGAP1 (−/−) . Cells expressing IQGAP1(CD) plasmid were not significantly different than cells expressing IQGAP1 plasmid (p = 0.99). (C) Representative images of phalloidin-stained actin filaments from cells as in A. (D) Quantification and statistics of actin filament morphology as in B (n = 20–41 cells). Cells expressing IQGAP1(CD) plasmid were not significantly different than cells expressing IQGAP1 plasmid (p = 0.11). (E) Representative images from cells as in A 12 h post-wounding event. Scale bars, 200 µm. (F) Quantification of wound healing assays in E. Histograms represent means from n = 3–4 independent assays (dots). (G) Summary of IQGAP1 actin filament plus-end activities highlighting differences in on-rates and average dwell time. IQGAP1 displaces plus-end factors >18-fold more than the mDia1-CP decision complex. In cells, IQGAP1-filament capping activity may promote more turnover of molecules on filament plus-ends.
Techniques Used: Expressing, Transfection, Fluorescence, Plasmid Preparation, Staining, Activity Assay
